Articles dans des revues avec comité de lecture (78)
  1. 63. Vandenberghe, P., Wlodarska, I., Michaux, L., Zachée, P., Boogaerts, M., Vanstraelen, D., Herregods, M.-C., van Hoof, A., Selleslag, D., Roufosse, F., Maerevoet, M., Verhoef, G., De Wolf, C., Cools, J., Gilliland, D. G., Hagemeijer, A., & Marynen, P. (2004). Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia, 18(4), 734-742. doi:10.1038/sj.leu.2403313
  2. 64. Goldman, M., Cogan, E., & Roufosse, F. (2004). Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy, 59(7), 673-689. doi:10.1111/j.1398-9995.2004.00465.x
  3. 65. Roufosse, F., Cogan, E., & Goldman, M. (2003). The hypereosinophilic syndrome revisited. Annual Review of Medicine, 54, 169-184. doi:10.1146/annurev.med.54.101601.152431
  4. 66. De Lavareille, A., Roufosse, F., Schmid-Grendelmeier, P., Roumier, A.-S., Schandené, L., Cogan, E., Simon, H.-U., & Goldman, M. (2002). High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. Journal of allergy and clinical immunology, 110, 476-479. doi:10.1067/mai.2002.127003
  5. 67. Cogan, E., Decaux, G., Neve, P., & Roufosse, F. (2002). Le service de médecine interne générale. Revue médicale de Bruxelles, 23(2), 97-100.
  6. 68. Roufosse, F., De Lavareille, A., Schandené, L., Cogan, E., & Goldman, M. (2001). Clones T chez des patients atteints du syndrome hyperéosinophilique idiopathique: Implications pronostiques et thérapeutiques. Revue Francaise d'Allergologie et d'Immunologie Clinique, 41(3), 301-305. doi:10.1016/S0335-7457(01)00035-1
  7. 69. Roufosse, F., Simonart, T., & Cogan, E. (2001). Skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome. British Journal of Dermatology, 144(3), 639. doi:10.1046/j.1365-2133.2001.04110_144_3.x
  8. 70. De Lavareille, A., Roufosse, F., Schandené, L., Stordeur, P., Cogan, E., & Goldman, M. (2001). Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo. European Journal of Immunology, 31, 1037-1046. doi:10.1002/1521-4141(200104)31:4<1037::AID-IMMU1037>3.0.CO;2-#
  9. 71. Roufosse, F., & Cogan, E. (2001). Idiopathic hypereosinophilic syndrome: from the clinic to the laboratory, from the laboratory to the clinic. Revue Medicale de Bruxelles, 22(2), 113-115.
  10. 72. Roufosse, F., Schandené, L., Cogan, E., & Goldman, M. (2000). Hypereosinophilies chroniques: Un modele de maladie Th2. La Revue du praticien, 50(6), 622-626.
  11. 73. Schandené, L., Roufosse, F., De Lavareille, A., Stordeur, P., Efira, A., Kennes, B., Cogan, E., & Goldman, M. (2000). Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood, 96(13), 4285-92. doi:10.1182/blood.v96.13.4285
  12. 74. Roufosse, F., Schandené, L., Sibille, C., Willard-Gallo, K., Kennes, B., Efira, A., Goldman, M., & Cogan, E. (2000). Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. British Journal of Haematology, 109, 540-548. doi:10.1046/j.1365-2141.2000.02097.x
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>